Ortoma AB (publ) (STO:ORT.B)

Verve Therapeutics Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	816	344	372	147	531	523
Market Cap Growth	53.34%	-7.47%	153.56%	-72.39%	1.65%	-27.32%
Enterprise Value	766	311	347	146	506	503
Last Close Price	22.00	9.28	10.50	7.40	26.80	29.00
PS Ratio	9.06	5.68	6.00	6.28	26.56	28.36
PB Ratio	4.55	2.13	2.14	1.28	4.09	5.04
P/TBV Ratio	4.56	2.13	2.15	1.30	4.13	5.10
P/FCF Ratio	24.15	-	27.85	-	-	-
P/OCF Ratio	24.02	-	27.85	-	-	-
EV/Sales Ratio	8.50	5.13	5.60	6.23	25.28	27.29
EV/FCF Ratio	22.67	-	25.99	-	-	-
Asset Turnover	0.47	0.33	0.36	0.16	0.17	0.16
Inventory Turnover	3.86	7.70	37.53	-	-	-
Quick Ratio	3.66	2.40	3.03	0.30	4.47	2.66
Current Ratio	4.62	3.01	3.16	0.32	4.54	2.71
Return on Equity (ROE)	3.46%	-6.93%	-15.20%	-12.89%	-9.23%	-8.14%
Return on Assets (ROA)	1.74%	-4.30%	-8.00%	-6.57%	-6.88%	-4.89%
Return on Capital (ROIC)	1.88%	-4.78%	-9.55%	-7.67%	-7.14%	-5.08%
Earnings Yield	0.75%	-3.38%	-5.88%	-10.74%	-2.03%	-1.68%
FCF Yield	4.14%	-6.43%	3.59%	-5.69%	-2.87%	-1.61%
Buyback Yield / Dilution	-2.04%	-26.01%	-48.48%	-1.93%	-8.27%	-14.45%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.